|
End-of-day quote
NSE India S.E.
11/09/2026
|
5-day change | 1st Jan Change | ||
| 1,978.90 INR | +0.82% |
|
+2.66% | +45.03% |
| 07/08 | Emcure Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 06, 2026 | |
| 06/08 | Emcure Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026 | CI |
| Market Cap | 375B 3.93B 3.39B 3.2B 2.91B 5.45B 5.48B 37.94B 14.63B 191B 14.75B 14.43B 604B | P/E 2027 * |
31.6x | P/E 2028 * | 25.5x |
|---|---|---|---|---|---|
| Enterprise Value | 382B 4B 3.45B 3.26B 2.96B 5.54B 5.58B 38.59B 14.88B 194B 15B 14.67B 614B | EV / Sales 2027 * |
3.6x | EV / Sales 2028 * | 3.11x |
| Free-Float |
18.24% | Yield 2027 * |
0.2% | Yield 2028 * | 0.24% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| EMCURE | End-of-day quote | |
Bombay S.E.
| EMCURE | Delayed |
Last Transcript : Emcure Pharmaceuticals Limited
| 1 day | +0.82% | ||
| 1 week | +2.66% | ||
| Current month | +6.66% | ||
| 1 month | -1.53% | ||
| 3 months | +13.98% | ||
| 6 months | +30.69% | ||
| Current year | +45.03% |
| 1 week | 1,889.9 |  | 1,999 |
| 1 month | 1,830.1 | | 2,012 |
| Current year | 1,381 | | 2,048 |
| 1 year | 1,260 | | 2,048 |
| 3 years | 889 | | 2,048 |
| 5 years | 889 | | 2,048 |
| 10 years | 889 | | 2,048 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/1981 | |
| Director of Finance/CFO | - | 01/10/2003 | |
| Compliance Officer | - | 04/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 73 | 23/07/2001 | |
| Chairman | 70 | - | |
| Director/Board Member | 75 | 16/04/1981 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.82% | +2.66% | +46.70% | - | 3.93B | |
| -0.65% | -2.93% | +47.70% | +86.17% | 994B | |
| -0.29% | -3.51% | +49.15% | +62.35% | 640B | |
| +0.83% | +0.26% | +17.76% | +72.25% | 454B | |
| -0.38% | -3.59% | +30.13% | +35.17% | 337B | |
| -0.09% | -13.54% | +13.34% | +24.95% | 261B | |
| -0.43% | -2.48% | -0.73% | +9.58% | 246B | |
| -1.34% | -13.70% | +36.53% | +44.96% | 204B | |
| -3.44% | -7.51% | -20.63% | -59.44% | 190B | |
| -0.75% | -4.82% | +25.46% | +87.14% | 178B | |
| Average | -0.57% | -4.91% | +24.54% | +40.35% | 350.87B | |
| Weighted average by Cap. | -0.50% | -4.41% | +30.98% | +54.95% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 106B 1.11B 956M 904M 820M 1.54B 1.55B 10.71B 4.13B 53.84B 4.16B 4.07B 170B | 120B 1.25B 1.08B 1.02B 926M 1.74B 1.75B 12.1B 4.67B 60.84B 4.7B 4.6B 193B |
| Net income | 11.87B 124M 107M 101M 91.89M 172M 173M 1.2B 463M 6.03B 466M 456M 19.1B | 14.59B 153M 132M 125M 113M 212M 213M 1.47B 569M 7.41B 573M 561M 23.47B |
| Net Debt | 6.38B 66.82M 57.62M 54.5M 49.42M 92.68M 93.25M 645M 249M 3.25B 251M 245M 10.27B | -3.28B -34.31M -29.59M -27.99M -25.38M -47.59M -47.88M -331M -128M -1.67B -129M -126M -5.28B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | INR 1,978.90 | +0.82% | 122,389 |
| 10/09/26 | INR 1,962.80 | +2.53% | 248,776 |
| 09/09/26 | INR 1,914.40 | -0.59% | 74,957 |
| 08/09/26 | INR 1,925.80 | -0.05% | 93,609 |
| 07/09/26 | INR 1,926.80 | -0.04% | 118,478 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EMCURE Stock
Select your edition
All financial news and data tailored to specific country editions
